Levetiracetam In Sodium Chloride Injection
Product Images NDC 14789-110

12 FDA label images from Nexus Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam In Sodium Chloride (NDC 14789-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lev1g 0009 01)

Structural Formula (Lev1g 0009 01)
Chemical structure of Levetiracetam, showing its molecular arrangement with a pyrrolidone ring attached to an ethyl group and an amide functional group.*
FDA Label Image

Figure 1 (Lev1g 0009 02)

Figure 1 (Lev1g 0009 02)
A bar graph comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The graph shows increasing percentages for the Levetiracetam groups compared to placebo, indicating statistical significance for treatment groups versus placebo.*
FDA Label Image

Figure 2 (Lev1g 0009 03)

Figure 2 (Lev1g 0009 03)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The chart shows increasing percentages of patients with the highest percentage in the Levetiracetam 2000 mg/day group. Statistical significance versus placebo is noted for both drug groups.*
FDA Label Image

Figure 3 (Lev1g 0009 04)

Figure 3 (Lev1g 0009 04)
A bar chart comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day groups. The Levetiracetam group shows a higher percentage of approximately 39.4%, while the placebo group shows about 14.4%. Statistical significance is indicated with an asterisk for Levetiracetam versus placebo.*
FDA Label Image

Figure 4 (Lev1g 0009 05)

Figure 4 (Lev1g 0009 05)
A bar graph comparing the percentage of patients between two groups: Placebo (N=84) showing 45.2% and Levetiracetam (N=79) showing 72.2%. The graph indicates a statistically significant difference, marked by an asterisk, favoring Levetiracetam over placebo.*
FDA Label Image

Nexus Pharmaceuticals Logo (Lev1g 0009 06)

FDA Label Image

Principal Display Panel – 5mg/ml Carton Label (Lev1g 0009 07)

Principal Display Panel – 5mg/ml Carton Label (Lev1g 0009 07)
Packaging label for Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL) intravenous infusion. The label indicates 10 single-use bags, prescription use only, and manufactured by Nexus Pharmaceuticals LLC. Storage and usage instructions are included, along with the NDC 14789-110-05 and barcode. The label features orange hexagonal graphics highlighting the strength and volume.*
FDA Label Image

Principal Display Panel – 5mg/ml Bag Label (Lev1g 0009 08)

Principal Display Panel – 5mg/ml Bag Label (Lev1g 0009 08)
Label for Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL) intravenous injection in a 100 mL single-dose container. The label states infusion over 15 minutes, storage instructions, and manufacturer Nexus Pharmaceuticals LLC, Lincolnshire, IL. Includes barcode, lot, and expiration date fields.*
FDA Label Image

Principal Display Panel – 10mg/ml Carton Label (Lev1g 0009 09)

Principal Display Panel – 10mg/ml Carton Label (Lev1g 0009 09)
Packaging label for Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg/100 mL (10 mg/mL) for intravenous infusion. The product is Rx only and comes in a package containing 10 single-use bags. Labeler is Nexus Pharmaceuticals LLC. The label includes storage instructions, cautions, and manufacturer details.*
FDA Label Image

Principal Display Panel – 10mg/ml Bag Label (Lev1g 0009 10)

Principal Display Panel – 10mg/ml Bag Label (Lev1g 0009 10)
Label for Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL) intravenous injection in a 100 mL single-dose container. Manufactured for Nexus Pharmaceuticals, Inc. The label includes usage instructions, storage recommendations, and a barcode. Contains 750 mg sodium chloride and buffering agents. For intravenous infusion only, with a recommended infusion period of 15 minutes.*
FDA Label Image

Principal Display Panel – 15mg/ml Carton Label (Lev1g 0009 11)

Principal Display Panel – 15mg/ml Carton Label (Lev1g 0009 11)
Packaging label for Levetiracetam in 0.54% Sodium Chloride Injection, 1500 mg per 100 mL (15 mg/mL) intravenous infusion. The box is labeled for 10 single-use bags and states Rx only. Manufactured by Nexus Pharmaceuticals LLC. The label includes storage instructions and cautions about container sterility and usage.*
FDA Label Image

Principal Display Panel – 15mg/ml Bag Label (Lev1g 0009 12)

Principal Display Panel – 15mg/ml Bag Label (Lev1g 0009 12)
Label for Levetiracetam in 0.54% Sodium Chloride Injection, 1500 mg/100 mL (15 mg/mL) intravenous injection. The 100 mL single-dose container is for infusion over 15 minutes. Manufactured by Nexus Pharmaceuticals LLC. The label includes storage instructions and usage cautions, with a barcode and lot/expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.